AS
Altshuler Shaham Portfolio holdings
AUM
$3.14B
1-Year Return
24.55%
This Quarter Return
+13.45%
1 Year Return
+24.55%
3 Year Return
+51.84%
5 Year Return
+71.45%
10 Year Return
–
AUM
$4.25B
AUM Growth
+$933M
(+28%)
Cap. Flow
+$574M
Cap. Flow
% of AUM
13.5%
Top 10 Holdings %
Top 10 Hldgs %
66.21%
Holding
431
New
106
Increased
115
Reduced
111
Closed
54
Top Buys
| 1 |
Consumers Staples Select Sector SPDR Fund
XLP
|
$467M |
| 2 |
Walmart
WMT
|
$226M |
| 3 |
Check Point Software Technologies
CHKP
|
$174M |
| 4 |
ICL Group
ICL
|
$126M |
| 5 |
ATVI
Activision Blizzard Inc.
ATVI
|
$91.9M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$430M |
| 2 |
Financial Select Sector SPDR Fund
XLF
|
$430M |
| 3 |
Mastercard
MA
|
$16.1M |
| 4 |
Tower Semiconductor
TSEM
|
$5.69M |
| 5 |
Ormat Technologies
ORA
|
$5.5M |
Sector Composition
| 1 | Technology | 30.13% |
| 2 | Financials | 19.76% |
| 3 | Consumer Discretionary | 17.08% |
| 4 | Consumer Staples | 5.55% |
| 5 | Healthcare | 4.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBIS
276
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.6B
| $30K | ﹤0.01% |
466
+165
| +55% | +$10.6K |
|
277
Dropbox
DBX
$8.06B
| $29K | ﹤0.01% |
1,522
+987
| +184% | +$18.8K |
|
278
Domo
DOMO
$603M
| $29K | ﹤0.01% |
+746
| New | +$29K |
|
279
STAAR Surgical
STAA
$1.38B
| $29K | ﹤0.01% |
514
+72
| +16% | +$4.06K |
|
280
Charles River Laboratories
CRL
$8.07B
| $28K | ﹤0.01% |
+125
| New | +$28K |
|
281
Inspire Medical Systems
INSP
$2.56B
| $28K | ﹤0.01% |
+217
| New | +$28K |
|
|
JMIA
282
Jumia Technologies
JMIA
$1.09B
| $28K | ﹤0.01% |
+3,549
| New | +$28K |
|
|
SPLK
283
DELISTED
Splunk Inc
SPLK
| $28K | ﹤0.01% |
150
+81
| +117% | +$15.1K |
|
|
NUAN
284
DELISTED
Nuance Communications, Inc.
NUAN
| $28K | ﹤0.01% |
853
| – | – |
|
285
Abbott
ABT
$231B
| $27K | ﹤0.01% |
247
-49
| -17% | -$5.36K |
|
286
Castle Biosciences
CSTL
$683M
| $27K | ﹤0.01% |
+534
| New | +$27K |
|
|
MODV
287
DELISTED
ModivCare
MODV
| $27K | ﹤0.01% |
+293
| New | +$27K |
|
|
LHCG
288
DELISTED
LHC Group LLC
LHCG
| $27K | ﹤0.01% |
+127
| New | +$27K |
|
|
VCRA
289
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $27K | ﹤0.01% |
+928
| New | +$27K |
|
290
AdaptHealth
AHCO
$1.29B
| $26K | ﹤0.01% |
+1,211
| New | +$26K |
|
|
AMED
291
DELISTED
Amedisys
AMED
| $26K | ﹤0.01% |
111
+3
| +3% | +$703 |
|
292
Amgen
AMGN
$153B
| $26K | ﹤0.01% |
103
-15
| -13% | -$3.79K |
|
293
Pinduoduo
PDD
$177B
| $26K | ﹤0.01% |
353
+165
| +88% | +$12.2K |
|
294
Protolabs
PRLB
$1.19B
| $26K | ﹤0.01% |
199
+96
| +93% | +$12.5K |
|
295
Repligen
RGEN
$7.01B
| $26K | ﹤0.01% |
177
+20
| +13% | +$2.94K |
|
296
Bio-Techne
TECH
$8.46B
| $26K | ﹤0.01% |
416
-2,384
| -85% | -$149K |
|
|
CTLT
297
DELISTED
CATALENT, INC.
CTLT
| $26K | ﹤0.01% |
306
+58
| +23% | +$4.93K |
|
298
Chemed
CHE
$6.79B
| $25K | ﹤0.01% |
52
+10
| +24% | +$4.81K |
|
299
Emergent Biosolutions
EBS
$404M
| $25K | ﹤0.01% |
245
+20
| +9% | +$2.04K |
|
300
Edwards Lifesciences
EW
$47.5B
| $25K | ﹤0.01% |
+307
| New | +$25K |
|